Bedford Laboratories has announced the FDA’s approval to begin shipping Pentostatin for Injection. This product is AP-rated and is equivalent to Nipent by Hospira, Inc. Pentostatin is indicated for the treatment of hairy cell leukemia.
The company will supply the latex-free injection as a sterile lyophilized powder in a single-dose vial containing 10 mg of pentostatin. Prescribing information is available upon request from the company.
(Source: Beford Laboratories, August 13, 2007